Role of arsenic (+3 oxidation state) methyltransferase in arsenic mediated APL treatment: an in vitro investigation

Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy

(2018) Tao Li et al.   Cell Death & Disease

HPLC-HG-AFS determination of arsenic species in acute promyelocytic leukemia ( APL) plasma and blood cells

(2017) Meihua Guo et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Exceptions in patterns of arsenic compounds in urine of acute promyelocytic leukaemia patients treated with As2O3

(2015) Zdenka Šlejkovec et al.   BIOMETALS

Varying responses of PML-RARA with different genetic mutations to arsenic trioxide

(2015) J. Liu et al.   BLOOD

Excretion patterns of arsenic and its metabolites in human saliva and urine after ingestion of Chinese seaweed

(2015) Dapeng Wang et al.   INTERNATIONAL JOURNAL OF ENVIRONMENTAL ANALYTICAL CHEMISTRY

How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia

(2014) M. A. Sanz et al.   BLOOD

Trivalent methylated arsenic metabolites induce apoptosis in human myeloid leukemic HL-60 cells through generation of reactive oxygen species

(2014) Kanwal Rehman et al.   Metallomics

Anticancer activity in human multiple myeloma U266 cells: synergy between cryptotanshinone and arsenic trioxide

(2013) Pei Liu et al.   Metallomics

Chemical and Clinical Development of Darinaparsin, a Novel Organic Arsenic Derivative

(2012) Alfonso Quintas-Cardama et al.   Anti-Cancer Agents in Medicinal Chemistry

Metabolism of arsenic and its toxicological relevance

(2012) Takayuki Watanabe et al.   ARCHIVES OF TOXICOLOGY

Role of Arsenic (+3 Oxidation State) Methyltransferase in Arsenic Metabolism and Toxicity

(2012) Daigo Sumi et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient

(2012) Noriyoshi Iriyama et al.   Journal of Hematology & Oncology

Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols

(2011) M. Breccia et al.   BLOOD

Arsenic methylation metabolism and liver injury of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment

(2011) Huihui Wang et al.   ENVIRONMENTAL TOXICOLOGY

Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia

(2011) E Lengfelder et al.   LEUKEMIA

Direct analysis and stability of methylated trivalent arsenic metabolites in cells and tissues

(2011) Jenna M. Currier et al.   Metallomics

PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3

(2010) Marion Jeanne et al.   CANCER CELL

Selenium-dependent and -independent transport of arsenic by the human multidrug resistance protein 2 (MRP2/ABCC2): implications for the mutual detoxification of arsenic and selenium

(2010) M. W. Carew et al.   CARCINOGENESIS

Metabolism of arsenic in human liver: the role of membrane transporters

(2009) Zuzana Drobná et al.   ARCHIVES OF TOXICOLOGY

Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome

(2009) M. Luesink et al.   BLOOD

Disruption of the Arsenic (+3 Oxidation State) Methyltransferase Gene in the Mouse Alters the Phenotype for Methylation of Arsenic and Affects Distribution and Retention of Orally Administered Arsenate

(2009) Zuzana Drobna et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway

(2008) Valérie Lallemand-Breitenbach et al.   NATURE CELL BIOLOGY